| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 05/10/2002 | WO2002016381A3 Composition and method for inhibiting platelet aggregation |
| 05/10/2002 | WO2001072288A3 Use of cdp-choline for the treatment of alcohol withdrawal syndrome |
| 05/10/2002 | WO2001068034B1 1, 2, 4-triazoloribonucleoside prodrugs and their administration to treat viral disease conditions |
| 05/10/2002 | WO2001028545A3 Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis |
| 05/10/2002 | CA2426815A1 Phase transfer catalyzed glycosidation of an indolocarbazole |
| 05/10/2002 | CA2426121A1 Atropisomers of asymmetric xanthene fluorescent dyes and methods of dna sequencing and fragment analysis |
| 05/09/2002 | US20020055510 Useful in the treatment of cancer. |
| 05/09/2002 | US20020055485 Method of treating arrhythmias |
| 05/09/2002 | US20020055484 Methods for modulating the axonal outgrowth of central nervous system neurons |
| 05/09/2002 | US20020055483 Treating hepatitus B, C and D; AIDS; antiproliferative agents |
| 05/09/2002 | US20020055482 Molecular constructs with a carcinoembryonic antigen (cea) transcriptional regulatory sequence |
| 05/09/2002 | US20020055473 Ribavirin-interferon alfa combination therapy for eradicating detectable HCV-RNA in patients having chronic hepatitis C infection |
| 05/08/2002 | EP1203004A1 HIGH AFFINITY TGF$g(g) NUCLEIC ACID LIGANDS AND INHIBITORS |
| 05/08/2002 | EP1202749A2 Enzyme catalyzed anti-infective therapeutic agents |
| 05/08/2002 | CN1348378A Method of promoting cervical and vaginal secretions |
| 05/07/2002 | US6384210 Injet print head having piezoelectric pump; head contains solvent having a boiling point above 150 degrees celsius, high surface tension and a specific viscosity; solvent does not have hydroxyl groups |
| 05/07/2002 | US6384019 Gemcitabine derivatives |
| 05/07/2002 | US6383794 Methods of producing high titer recombinant adeno-associated virus |
| 05/07/2002 | CA2230059C Propargylethoxyamino nucleotides |
| 05/02/2002 | WO2001092282A3 Methods and compositions for treating flaviviruses and pestiviruses |
| 05/02/2002 | WO2001090121A3 Methods and compositions for treating hepatitis c virus |
| 05/02/2002 | WO2001085165A3 Combination of lipoic acid and c1 donors for the treatment of disorders of the central nervous system |
| 05/02/2002 | US20020052492 Process for the production of 2-halo-6-aminopurine derivatives |
| 05/02/2002 | US20020052491 Method for the production of 2-chloro-2' -deoxyadenosine (cladribine) and its 3,5-di-O-p-toluoyl derivative |
| 05/02/2002 | US20020052482 Covalently linked oligonucleotide minor grove binder conjugates |
| 05/02/2002 | US20020052345 Novel prodrugs for phosphorus-containing compounds |
| 05/02/2002 | US20020052337 Composition and method for inhibiting platelet aggregation |
| 05/02/2002 | US20020052037 Ribozyme for use as tool in genetic engineering |
| 05/02/2002 | US20020051991 Rapid generation of diverse nucleoside and nucleotide libraries |
| 05/02/2002 | EP1201769A2 Gene expression monitoring using universal arrays |
| 05/02/2002 | EP1201678A1 Novel bicyclonucleoside analogues |
| 05/02/2002 | EP1201676A2 PNA-DNA-PNA chimeric macromolecules |
| 05/02/2002 | EP1200478A1 Method for assaying compounds affecting smooth muscle contractile state |
| 05/02/2002 | EP1200455A1 Enzyme catalyzed therapeutic activation |
| 05/02/2002 | EP1200131A2 Compositions and methods for targeted enzymatic release of cell regulatory compounds |
| 05/02/2002 | EP1200130A2 Methods for treating therapy-resistant tumors |
| 05/02/2002 | EP1200097A2 Method for controlling the fidelity and the execution of reverse transcriptase by incorporating and polymerising nucleotide analogues accepted as substrates of the reverse transcription response without blocking its elongation |
| 05/02/2002 | EP0879056B1 Modulation of th1/th2 cytokine expression by ribavirin in activated t-lymphocytes |
| 05/02/2002 | EP0841907B1 Use of agonists or antagonists of p2 purinoceptors for the prevention of glutamate-evoked cytotoxicity |
| 05/02/2002 | EP0840740B1 New inhibitors of platelet aggregation |
| 05/01/2002 | CN1347418A Novel nucleosides and oligonucleotide analogues |
| 04/30/2002 | US6380378 Biosynthesis |
| 04/30/2002 | US6380368 Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines |
| 04/30/2002 | US6379954 Amido and peptido modified catalytic oligonucleotides |
| 04/30/2002 | US6379936 With crotonobetainyl-coenzyme a and l(-)-carnitine dehydratase, adding d(+)-carnitine and isolating l-isomer |
| 04/30/2002 | US6379895 Photolithographic and other means for manufacturing arrays |
| 04/30/2002 | CA2062496C Avermectin compounds with a 6,5-spiroketal ring system |
| 04/25/2002 | WO2002033128A2 Multiplex quantification of nucleic acids in diseased cells |
| 04/25/2002 | WO2002032920A2 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 04/25/2002 | WO2002032912A2 Phosphinoamidite carboxylates and analogs thereof in the synthesis of oligonucleotides having reduced internucleotide charge |
| 04/25/2002 | WO2001020040A3 Method and compositions for evaluating resolution of nucleic acid separation systems |
| 04/25/2002 | US20020049182 Administering to a mammal a composition containing pyrimidine nucleotide precursors in amounts sufficient to treat symptoms resulting from mitochondrial respiratory chain deficiencies. |
| 04/25/2002 | CA2426196A1 Simultaneous quantification of nucleic acids in diseased cells |
| 04/24/2002 | EP1198589A1 Tenascin-c nucleic acid ligands |
| 04/24/2002 | EP1137812A4 Dna-protein fusions and uses thereof |
| 04/24/2002 | CN1083450C Processes for preparing intermediate product used in method of diastereoselective syntheses of nucleosides |
| 04/23/2002 | US6376472 Compounds having antihypertensive, cardioprotective, anti-ischemic and antilipolytic properties |
| 04/23/2002 | US6376183 Hybridizing primer to target and effecting chain extension/chain termination, using primer selected from presynthesised set of walking primers of which annealing temperatures are raised and/or annealing properties improved |
| 04/18/2002 | WO2002030944A2 Fluorescent nucleobase conjugates having anionic linkers |
| 04/18/2002 | WO2002030942A2 Anhydro sugar derivatives of indolocarbazoles |
| 04/18/2002 | WO2002030941A2 Topoisomerase inhibitors |
| 04/18/2002 | WO2002030354A2 Uridine therapy for patients with elevated purine levels |
| 04/18/2002 | WO2002011668A3 5'-deoxy-n-(substituted oxycarbonyl)-5-fluorocytosine and derivatives thereof, method of preparing same, and anticancer composition comprising same as active ingredients |
| 04/18/2002 | WO2002010432A3 Triphosphate oligonucleotide modification reagents and uses thereof |
| 04/18/2002 | WO2001096353A3 3'-PRODRUGS OF 2'-DEOXY-β-L-NUCLEOSIDES |
| 04/18/2002 | WO2001045691A3 Method of treating gastrointestinal tract disease with purinergic receptor agonists |
| 04/18/2002 | US20020045744 Producing compounds having sugar-moiety hydroxyl groups or halogen atoms reduced in nucleic acids by allowing O-thiocarbonyl derivatives or halogenated derivatives in the sugar-moiety react with hypophosphorous acids or salts |
| 04/18/2002 | US20020045738 Oligonucleotide-binding e-tag probe compositions |
| 04/18/2002 | US20020045595 N6 heterocyclic 8-modified adenosine derivatives |
| 04/18/2002 | US20020045276 Analyte assay using particulate labels |
| 04/18/2002 | US20020045222 Compositions and methods for saccharide synthesis |
| 04/18/2002 | US20020045221 Condensing the 3'-OH or 5'-OH group of a support-bound nucleoside or oligonucleotide with a monomeric nucleoside phosphoramidite having a carbonate-protected hydroxyl group; treating the intermediate provided with a deprotecting reagent |
| 04/18/2002 | US20020045180 Useful as substrates for polymerase enzymes; used in preparing fluorescently-labeled nucleotides useful as substrates for thermostable polymerases |
| 04/18/2002 | CA2425593A1 Uridine therapy for patients with elevated purine levels |
| 04/18/2002 | CA2424971A1 Topoisomerase inhibitors |
| 04/18/2002 | CA2424438A1 Anhydro sugar derivatives of indolocarbazoles |
| 04/17/2002 | EP1196396A1 Conjugates of sodium channel blockers and methods of using the same |
| 04/17/2002 | EP0663830B1 Method of treating lung disease with uridine triphosphates |
| 04/16/2002 | US6372907 Labelled rhodamine dye-polypeptide conjugate, or salt thereof, comprising rhodamine-type parent xanthene ring substituted at xanthene c-9 carbon with substituted phenyl ring |
| 04/16/2002 | US6372725 Viricides, anticarcinogenic and antitumor agents; side effect reduction |
| 04/16/2002 | CA2046607C Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
| 04/12/2002 | CA2358831A1 Gene expression monitoring using universal arrays |
| 04/11/2002 | WO2002029003A2 Massive parallel method for decoding dna and rna |
| 04/11/2002 | WO2002028875A2 Improved synthesis of purine locked nucleic acid analogues |
| 04/11/2002 | WO2002028874A2 Tumor proliferation inhibitors |
| 04/11/2002 | US20020042392 Anticancer agents |
| 04/11/2002 | US20020042391 Anticancer agents; viricides |
| 04/11/2002 | US20020042390 Therapy for central nervous system disorders; administeringnucleoside |
| 04/11/2002 | US20020042071 Sequencing nucleic acid using labeled nucleotide phosphate probes |
| 04/11/2002 | CA2425264A1 Tumor proliferation inhibitors |
| 04/10/2002 | EP1194441A2 Thiophene a2a receptor agonists |
| 04/10/2002 | EP1194440A2 Induction of pharmacological stress with adenosine receptor agonists |
| 04/10/2002 | EP0901499B1 Adenosine derivatives |
| 04/10/2002 | EP0797580B1 Nucleoside derivatives with photolabile protective groups |
| 04/10/2002 | CN1343673A Thiophosphamino acid ester compound containing 3'-azido-deoxythymidine and its preparing process |
| 04/10/2002 | CN1343672A 3'-azido-deoxythymidine-5'-thiopyhosphamino acid ester compound and its preparing process |
| 04/09/2002 | US6369040 Incorporating a complementary sequences for herpes, papilloma and other viruses |
| 04/09/2002 | US6368573 Measuring myocardial function in mammal |
| 04/04/2002 | WO2000061594A3 Nucleoside derivatives with photo-unstable protective groups |
| 04/04/2002 | US20020040050 Immunosuppressive agents |